Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine

I. Torshin, O. Gromova, Z. Kobalava
{"title":"Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine","authors":"I. Torshin, O. Gromova, Z. Kobalava","doi":"10.17749/2070-4909.2019.12.2.91-114","DOIUrl":null,"url":null,"abstract":"The subject of this article is the obvious crisis of evidence-based medicine in the 21st century. As a typical example of a contemporary “evidence-based study”, here we analyze in detail a text published in 2018 in the Cochrane Database Syst Rev journal under the code number “CD00317F. The authors claim that ω -3 polyunsaturated fatty acids (PUFAs) are not effective either for the prevention of cardiovascular mortality or for any other outcomes mentioned by the authors. A detailed analysis of this text, however, pointed to gross violations of data collection and processing. By using modern mathematical methods for big data analysis we were able to demonstrate clearly that the authors of the text CD003177 used clinically heterogeneous cohorts of patients. We then selected a subsample of 19 clinically homogeneous studies (total of 64771 patients) and conducted a meta-analysis of this data. According to the results, an increase in consumption of ω -3 PUFA -eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids - by 1 g/day was associated with a significant decrease in the risk of mortality by an average of 5% (OR - 0.945, 95% CI - 0.907-1.008; P=0.054). This meta-analysis was based on the modified clinical, laboratory and anthropometric criteria in the selected studies. In addition, we used the most important characteristics of ω -3 PUFAs pharmaceutical forms and the modern statistical analysis of biomedical data. With the above modifications, we managed to select a homogeneous subsample of clinically relevant studies. We also applied methods of sentiment analysis to demonstrate a subjective approach used by the above authors regarding the role of PUFAs in the prevention of cardiovascular morbidity. Using the language of today social media, some adepts of evidence-based medicine implement propaganda techniques to literally “repress” ω -3 PUFAs.","PeriodicalId":201824,"journal":{"name":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","volume":"55 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17749/2070-4909.2019.12.2.91-114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

The subject of this article is the obvious crisis of evidence-based medicine in the 21st century. As a typical example of a contemporary “evidence-based study”, here we analyze in detail a text published in 2018 in the Cochrane Database Syst Rev journal under the code number “CD00317F. The authors claim that ω -3 polyunsaturated fatty acids (PUFAs) are not effective either for the prevention of cardiovascular mortality or for any other outcomes mentioned by the authors. A detailed analysis of this text, however, pointed to gross violations of data collection and processing. By using modern mathematical methods for big data analysis we were able to demonstrate clearly that the authors of the text CD003177 used clinically heterogeneous cohorts of patients. We then selected a subsample of 19 clinically homogeneous studies (total of 64771 patients) and conducted a meta-analysis of this data. According to the results, an increase in consumption of ω -3 PUFA -eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids - by 1 g/day was associated with a significant decrease in the risk of mortality by an average of 5% (OR - 0.945, 95% CI - 0.907-1.008; P=0.054). This meta-analysis was based on the modified clinical, laboratory and anthropometric criteria in the selected studies. In addition, we used the most important characteristics of ω -3 PUFAs pharmaceutical forms and the modern statistical analysis of biomedical data. With the above modifications, we managed to select a homogeneous subsample of clinically relevant studies. We also applied methods of sentiment analysis to demonstrate a subjective approach used by the above authors regarding the role of PUFAs in the prevention of cardiovascular morbidity. Using the language of today social media, some adepts of evidence-based medicine implement propaganda techniques to literally “repress” ω -3 PUFAs.
关于循证医学专家对ω -3多不饱和脂肪酸的“抑制”
本文的主题是21世纪循证医学的明显危机。作为当代“循证研究”的一个典型例子,我们在这里详细分析2018年发表在Cochrane Database system Rev期刊上的一篇文章,代码为“CD00317F”。作者声称,ω -3多不饱和脂肪酸(PUFAs)对预防心血管死亡或作者提到的任何其他结果都无效。然而,对这一案文的详细分析指出,在数据收集和处理方面存在严重违规行为。通过使用现代数学方法进行大数据分析,我们能够清楚地证明文本CD003177的作者使用了临床异质患者队列。然后,我们选择了19个临床同质研究的亚样本(共64771例患者),并对这些数据进行了荟萃分析。结果显示,ω -3 PUFA -二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)摄入量每增加1克/天,死亡风险平均显著降低5% (OR - 0.945, 95% CI - 0.907-1.008;P = 0.054)。本荟萃分析是基于所选研究中修改的临床、实验室和人体测量标准。此外,我们还利用了ω -3 PUFAs药物形态的最重要特征和生物医学数据的现代统计分析。通过上述修改,我们成功地选择了临床相关研究的均匀亚样本。我们还应用情感分析方法来证明上述作者使用的关于PUFAs在预防心血管疾病中的作用的主观方法。利用当今社交媒体的语言,一些循证医学专家实施宣传技术,从字面上“抑制”ω -3 pufa。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信